NDC 68151-4769 Pentasa
View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 68151 - Carilion Materials Management
- 68151-4769 - Pentasa
Product Characteristics
BLUE (C48333 - BLUE)
Product Packages
NDC Code 68151-4769-8
Package Description: 1 CAPSULE in 1 PACKAGE
Product Details
What is NDC 68151-4769?
What are the uses for Pentasa?
Which are Pentasa UNII Codes?
The UNII codes for the active ingredients in this product are:
- MESALAMINE (UNII: 4Q81I59GXC)
- MESALAMINE (UNII: 4Q81I59GXC) (Active Moiety)
Which are Pentasa Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- CASTOR OIL (UNII: D5340Y2I9G)
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- STEARIC ACID (UNII: 4ELV7Z65AP)
- TALC (UNII: 7SEV7J4R1U)
- D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)
- FD&C BLUE NO. 1 (UNII: H3R47K3TBD)
- FD&C GREEN NO. 3 (UNII: 3P3ONR6O1S)
- GELATIN (UNII: 2G86QN327L)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
What is the NDC to RxNorm Crosswalk for Pentasa?
- RxCUI: 206791 - Pentasa 250 MG Extended Release Oral Capsule
- RxCUI: 206791 - mesalamine 250 MG Extended Release Oral Capsule [Pentasa]
- RxCUI: 314092 - mesalamine 250 MG Extended Release Oral Capsule
- RxCUI: 314092 - mesalazine 250 MG Extended Release Oral Capsule
* Please review the disclaimer below.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".